Mohamed Mostafa is the Chief Executive Officer of PDC-CRO and serves on its Board of Directors. Mohamed leads a workforce in supporting Pharmaceuticals, Biotech companies and Research Institutions on the clinical development and transformational research. Mohamed’s inspiration and passion for clinical research led him to focus on how clinical research can improve patient’s lives. Over two decades of versed experience, he dedicated his efforts to expand research capabilities and infrastructure to provide patients an option to access new treatments.
PDC is a leading CRO in the Middle East and Africa Region that focuses on early-stage clinical development, operational management of clinical trials and regulatory services. More recently, the company’s rapid response to the COVID-19 pandemic drove a coordination of global and regional initiatives to safeguard the health of people and ensure vaccines, life-saving medicines and products reach patients and communities in need.
Mohamed holds a bachelor’s degree in Pharmaceutical Science from Egypt and is currently responsible for the overall management and strategic initiatives within the organization. Prior to that, he was heading the Clinical Operations across different CROs and Pharmaceutical Companies like Novartis and Roche. In his capacity, he was responsible for various scientific initiatives with local and international partners and worked closely with regulatory agencies across the region on various guidelines and strategic plans.
